These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 31995623)

  • 1. Retraction: uPAR/Cathepsin B Overexpression Reverse Angiogenesis by Rescuing FAK Phosphorylation in uPAR/Cathepsin B Down Regulated Meningioma.
    PLOS ONE Editors
    PLoS One; 2020; 15(1):e0228681. PubMed ID: 31995623
    [No Abstract]   [Full Text] [Related]  

  • 2. uPAR/cathepsin B overexpression reverse angiogenesis by rescuing FAK phosphorylation in uPAR/cathepsin B down regulated meningioma.
    Gupta R; Nalla AK; Gogineni VR; Chetty C; Bhoopathi P; Klopfenstein JD; Tsung AJ; Mohanam S; Rao JS
    PLoS One; 2011 Feb; 6(2):e17123. PubMed ID: 21347260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of uPAR and cathepsin B retards cofilin dephosphorylation.
    Gondi CS; Kandhukuri N; Kondraganti S; Gujrati M; Olivero WC; Dinh DH; Rao JS
    Int J Oncol; 2006 Mar; 28(3):633-9. PubMed ID: 16465367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.
    Gondi CS; Lakka SS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Tung CH; Weissleder R; Rao JS
    Cancer Res; 2004 Jun; 64(12):4069-77. PubMed ID: 15205313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.
    Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Oncogene; 2004 Nov; 23(52):8486-96. PubMed ID: 15378018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
    Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo.
    Aguirre Ghiso JA
    Oncogene; 2002 Apr; 21(16):2513-24. PubMed ID: 11971186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
    Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
    Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma.
    Kruszewski WJ; Rzepko R; Wojtacki J; Skokowski J; Kopacz A; Jaśkiewicz K; Drucis K
    Neoplasma; 2004; 51(1):38-43. PubMed ID: 15004658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.
    Kargiotis O; Chetty C; Gogineni V; Gondi CS; Pulukuri SM; Kyritsis AP; Gujrati M; Klopfenstein JD; Dinh DH; Rao JS
    Int J Oncol; 2008 Nov; 33(5):937-47. PubMed ID: 18949356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway.
    Gondi CS; Kandhukuri N; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2007 Jul; 31(1):19-27. PubMed ID: 17549401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.
    Werle B; Kotzsch M; Lah TT; Kos J; Gabrijelcic-Geiger D; Spiess E; Schirren J; Ebert W; Fiehn W; Luther T; Magdolen V; Schmitt M; Harbeck N
    Anticancer Res; 2004; 24(6):4147-61. PubMed ID: 15736466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction: Co-Depletion of Cathepsin B and uPAR Induces G0/G1 Arrest in Glioma via FOXO3a Mediated p27Kip1 Upregulation.
    PLOS ONE Editors
    PLoS One; 2020; 15(1):e0228690. PubMed ID: 31995632
    [No Abstract]   [Full Text] [Related]  

  • 14. Retraction: Downregulation of uPAR and Cathepsin B Induces Apoptosis via Regulation of Bcl-2 and Bax and Inhibition of the PI3K/Akt Pathway in Gliomas.
    PLOS ONE Editors
    PLoS One; 2020; 15(1):e0228688. PubMed ID: 31995620
    [No Abstract]   [Full Text] [Related]  

  • 15. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
    Lah TT; Nanni I; Trinkaus M; Metellus P; Dussert C; De Ridder L; Rajcević U; Blejec A; Martin PM
    J Neurosurg; 2010 May; 112(5):940-50. PubMed ID: 19747051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction Note to: uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma.
    Malla RR; Gopinath S; Gondi CS; Alapati K; Dinh DH; Tsung AJ; Rao JS
    J Neurooncol; 2021 Apr; 152(2):417. PubMed ID: 33710476
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoelectron microscopy of the receptor for urokinase plasminogen activator and cathepsin D in the human breast cancer cell line MDA-MB-231.
    Bastholm L; Elling F; Brünner N; Nielsen MH
    APMIS; 1994 Apr; 102(4):279-86. PubMed ID: 8011305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
    Besch R; Berking C; Kammerbauer C; Degitz K
    Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion.
    Annis MG; Ouellet V; Rennhack JP; L'Esperance S; Rancourt C; Mes-Masson AM; Andrechek ER; Siegel PM
    Breast Cancer Res; 2018 Jan; 20(1):9. PubMed ID: 29382358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase-type plasminogen activator receptor regulates apoptotic sensitivity of colon cancer HCT116 cell line to TRAIL via JNK-p53 pathway.
    Liu X; Qiu F; Liu Z; Lan Y; Wang K; Zhou PK; Wang Y; Hua ZC
    Apoptosis; 2014 Oct; 19(10):1532-44. PubMed ID: 25113506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.